CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY / (DEFICIT) - USD ($)		Preferred Stock [Member] Series A [Member]	Preferred Stock [Member] Series Seed [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated OCI [Member]	Total
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		$ 315	$ 2,108	$ 888	$ 8,811,647	$ (9,767,619)	$ 118,859	$ (833,802)
Beginning balance (in shares)		314,505	2,108,405	888,184
Retroactive application of recapitalization		$ (315)	$ (2,108)	$ 503	1,920	0	0	0
Retroactive application of recapitalization (in shares)		(314,505)	(2,108,405)	13,026,925
Adjusted balance, beginning of period at Dec. 31, 2019		$ 0	$ 0	$ 1,392	8,813,567	(9,767,619)	118,859	(833,802)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of preferred stock	[1]	$ 0	$ 0	$ 223	1,429,782	0	0	1,430,005
Issuance of preferred stock (in shares)	[1]	0	0	2,225,396
Issuance of non-vested stock awards	[1]	$ 0	$ 0	$ 914	20,822	0	0	21,736
Issuance of non-vested stock awards (in shares)	[1]	0	0	9,135,138
Repurchase of shares	[1]	$ 0	$ 0	$ (24)	(139,910)	(12,857)	0	(152,792)
Repurchase of shares (in shares)	[1]	0	0	(242,245)
Recognition of stock grant plan		$ 0	$ 0	$ 0	413,396	0	0	413,396
Net loss		0	0	0	0	(1,418,037)	0	(1,418,037)
Other comprehensive loss		0		0	0	0	(13,544)	(13,544)
Ending balance at Sep. 30, 2020		$ 0	$ 0	$ 2,503	10,537,657	(11,198,513)	105,315	(553,039)
Ending balance (in shares) at Sep. 30, 2020		0	0	25,033,398
Adjusted balance, beginning of period (in shares) at Dec. 31, 2019		0	0	13,915,109
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		$ 0	$ 0	$ 2,133	10,314,200	(10,436,840)	107,357	(13,150)
Beginning balance (in shares)		0	0	21,332,235
Issuance of non-vested stock awards	[1]	$ 0	$ 0	$ 376	8,559	0	0	8,935
Issuance of non-vested stock awards (in shares)	[1]	0	0	3,755,010
Repurchase of shares	[1]	$ 0	$ 0	$ (5)	(21,730)	(12,857)	0	(34,593)
Repurchase of shares (in shares)	[1]	0	0	(53,848)
Recognition of stock grant plan		$ 0	$ 0	$ 0	236,628	0	0	236,628
Net loss		0	0	0	0	(748,816)	0	(748,816)
Other comprehensive loss		0	0	0	0	0	(2,042)	(2,042)
Ending balance at Sep. 30, 2020		$ 0	$ 0	$ 2,503	10,537,657	(11,198,513)	105,315	(553,039)
Ending balance (in shares) at Sep. 30, 2020		0	0	25,033,398
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		$ 845	$ 2,096	$ 3,017	10,990,307	(12,901,518)	111,780	(1,793,473)
Beginning balance (in shares)		844,037	2,095,592	3,017,057
Retroactive application of recapitalization		$ (845)	$ (2,096)	$ (514)	3,455	0	0	0
Retroactive application of recapitalization (in shares)		(844,037)	(2,095,592)	22,016,341
Adjusted balance, beginning of period at Dec. 31, 2020		$ 0	$ 0	$ 2,503	10,993,762	(12,901,518)	111,780	(1,793,473)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Business combination and PIPE financing		$ 0	$ 0	$ 2,107	108,005,876	0	0	108,007,984
Business combination and PIPE financing (in shares)		0	0	21,072,549
Share capital increase from warrants exercise		$ 0	$ 0	$ 2	262,175	0	0	262,177
Share capital increase from warrants exercise (in shares)		0	0	22,798
Share capital increase		$ 0	$ 0	$ 512	37,923,348	0	0	37,923,860
Share capital increase (in shares)		0	0	5,124,846
Stock based compensation expense		$ 0	$ 0	$ 0	4,078,513	0	0	4,078,513
Net loss		0	0	0	0	(11,517,360)	0	(11,517,360)
Other comprehensive loss		0		0	0	0	(829,108)	(829,108)
Ending balance at Sep. 30, 2021		$ 0	$ 0	$ 5,125	161,263,673	(24,418,878)	(717,328)	136,132,592
Ending balance (in shares) at Sep. 30, 2021		0	0	51,253,591
Adjusted balance, beginning of period (in shares) at Dec. 31, 2020		0	0	25,033,398
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		$ 0	$ 0	$ 4,613	119,964,708	(13,139,155)	(176,457)	106,653,709
Beginning balance (in shares)		0	0	46,128,745
Share capital increase		$ 0	$ 0	$ 512	37,923,348	0	0	37,923,860
Share capital increase (in shares)		0	0	5,124,846
Stock based compensation expense		$ 0	$ 0	$ 0	3,375,616	0	0	3,375,616
Net loss		0	0	0	0	(11,279,722)	0	(11,279,722)
Other comprehensive loss		0	0	0	0	0	(540,871)	(540,871)
Ending balance at Sep. 30, 2021		$ 0	$ 0	$ 5,125	$ 161,263,673	$ (24,418,878)	$ (717,328)	$ 136,132,592
Ending balance (in shares) at Sep. 30, 2021		0	0	51,253,591

[1] The amounts have been retroactively restated to give effect to the recapitalization transaction.